# IBRUTINIB
> **ANDA211350** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2021-03-01
## Drug
- **FDA Application Number:** ANDA211350
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBRUTINIB
- **Generic name:** Ibrutinib
- **Active ingredients:** IBRUTINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2021-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211350)
---
*AI Analytics · CC0 1.0*